Table 2.
Clinicopathological characteristics of TNBC
| Clinicopathological parameters | SOX10 negative | SOX10 positive | Total | P |
|---|---|---|---|---|
| Age (y, mean ± SD) | 58.17 ± 14.56 | 58.83 ± 13.626 | − | .63 |
| Size (cm, mean ± SD) | 2.7 ± 1.9 | 3.1 ± 2.7 | − | .076 |
| TNBC subtypes | ||||
| BL1 | 4 (40%) | 6 (60%) | 10 (21.7%) | .273 |
| MSL | 6 (75%) | 2 (25%) | 8 (17.4%) | |
| LAR | 4 (80%) | 1 (20%) | 5 (10.9%) | |
| IM | 5 (83.3%) | 1 (16.7%) | 6 (13%) | |
| BL2 | 4 (80%) | 1 (20%) | 5 (10.9%) | |
| M | 3 (75%) | 1 (25%) | 4 (8.7%) | |
| UNS | 3 (37.5%) | 5 (62.5%) | 8 (17.4%) | |
| Total | 29 | 17 | 46 | |
| T stage | ||||
| T1 | 13 (44.85) | 9 (50%) | 22 (46.8%) | .376 |
| T2 | 13 (44.8%) | 5 (27.8%) | 18 (38.3%) | |
| T3 | 3 (10.3%) | 4 (22.2%) | 7 (14.9%) | |
| Total | 29 | 18 | 47 | |
| N stage | ||||
| N0 | 19 (67.9%) | 13 (76.5%) | 32 (71.1%) | .258 |
| N1 | 5 (17.9%) | 4 (23.5%) | 9 (20%) | |
| N3 | 4 (14.3%) | 0 (0%) | 4 (8.9%) | |
| Total | 28 | 17 | 45 | |
| Recurrence | ||||
| Absent | 23 (76.7%) | 15 (83.3%) | 38 (79.2%) | .722 |
| Present | 7 (23.3%) | 3 (30.0%) | 10 (20.8%) | |
| Total | 30 | 18 | 48 |